MarcVervloet NetherlandsRadboud University Medical center, The Netherlands

MarcVervloet
Upload Picture
https://storage.unitedwebnetwork.com/files/1099/cf77b8532506cca12a6a874f7c9b312c.jpeg
First Name
Marc
Last Name
Vervloet
Institution
Country.
Netherlands

Friday, February 7, 2025

Time Session
9:45 a.m.
11:15 a.m.
CKD-MBD Insights and Innovations for 2025 and Beyond: No Bone Left Uncovered
LF01
ArvindBagga Chair India
UttaraDas Chair IndiaAll IndiaInstitute of Medical Science Mangalagiri
  • What Should a Clinician Know About CKD-MBD in 2025?
    LF01-01
    HanneJoergensen Speaker DenmarkAarhus University
  • CKD-MBD in Children and Young Adults: What's the Difference?
    LF01-02
    SukanyaGovindan Speaker IndiaMehta Children's Hospitals and MGM healthcare, Chennai, India
  • Progress in CKD-driven Vascular Calcification: From Bench to Bedside
    LF01-03
    MarcVervloet Speaker NetherlandsRadboud University Medical center, The Netherlands
  • How to Use Serum Biomarkers for Optimal Management of CKD-MBD
    LF01-04
    SandroMazzaferro Speaker ItalySapienza University of Rome, Italy
  • Q&A
    LF01-05
Gulmohar Hall 302